COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1598: Articles 15971-15980  | Next

Global-scale analysis and longitudinal assessment of COVID-19 incidence in the first six months
GHOSH, S., ROY, S. S.
10.1101/2021.03.31.21254739 — Posted: 2021-04-06
DRUL for School: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2
Frank, M., Blachere, N. E., Parveen, S., Hacisuleyman, E., Fak, J., Luna, J. M., Michailidis, E., Wright, S., Stark, P., Campbell, A. H., Foo, A., Sakmar, T. P., Huffman, V., Bergh, M., Goldfarb, A., Mansisidor, A., Patriotis, A. L., Palmquist, K. H., Poulton, N., Leicher, R., Vargas, C. D., Duba, I., Hurley, A., Colagreco, J. P., Pagane, N., Orange, D. E., Mora, K., Rakeman, J. L., Fowler, R. C., Fernandes, H., Lamendola-Essel, M. F., Didkovsky, N., Silvera, L., Masci, J., Allen, M., Rice, C. M., Darnell, R. B.
10.1101/2021.04.03.21254873 — Posted: 2021-04-06
Implementation of SARS-CoV-2 monoclonal antibody infusion sites at three medical centers in the United States: Strengths and challenges assessment to inform COVID-19 pandemic and future public health emergency use
Lambrou, A. S., Redd, J. T., Stewart, M. A., Rainwater-Lovett, K., Thornhill, J. K., Hayes, L., Smith, G., Thorp, G. M., Tomaszewski, C., Edward, A., Elias Calles, N., Amox, M., Merta, S., Pfundt, T., Callahan, V., Tewell, A., Scharf-Bell, H., Imbriale, S., Freeman, J. D., Anderson, M., Kadlec, R. P.
10.1101/2021.04.05.21254707 — Posted: 2021-04-06
Replication of LZTFL1 gene region as a susceptibility locus for COVID-19 in Latvian population.
Rescenko, R., Peculis, R., Ustinova, M., Ansone, L., Litvina, H. D., Terentjeva, A., Birzniece, L., Megnis, K., Kolesova, O., Rozentale, B., Viksna, L., Rovite, V., Klovins, J.
10.1101/2021.03.31.21254708 — Posted: 2021-04-06
Quantifying Face Mask Comfort
Koh, E., Ambatipudi, M., Boone, D. L., Luehr, J. B. W., Blaise, A., Gonzalez, J., Sule, N., Mooney, D. J., He, E. M.
10.1101/2021.03.31.21254723 — Posted: 2021-04-06
Efficient Maternal to Neonatal transfer of SARS-CoV-2 and BNT162b2 antibodies
Beharier, O., Plitman Mayo, R., Raz, T., Nahum Sacks, K., Schreiber, L., Suissa-Cohen, Y., Chen, R., Gomez-Tolub, R., Hadar, E., Gabbay-Benziv, R., Jaffe Moshkovich, Y., Biron-Shental, T., Shechter-Maor, G., Farladansky-Gershnabel, S., Yitzhak Sela, H., Benyamini-Raischer, H., Sela, N. D., Goldman-Wohl, D., Shulman, Z., Many, A., Barr, H., Yagel, S., Neeman, M., Kovo, M.
10.1101/2021.03.31.21254674 — Posted: 2021-04-06
Humoral response to Pfizer mRNA vaccine against SARS CoV2, in patients with autoimmune inflammatory rheumatic diseases and the impact on the rheumatic disease activity
Braun-Moscovici, Y., Kaplan, M., Markovits, D., Giryes, S., Toledano, K., Tavor, Y., Dolnikov, K., Balbir-Gurman, A.
10.1101/2021.04.02.21254493 — Posted: 2021-04-06
High SARS-CoV-2 attack rates following exposure during singing events in the Netherlands, September-October 2020
Shah, A. A., Dusseldorp, F., Veldhuijzen, I. K., te Wierik, M. J. M., Bartels, A., Schijven, J., Vermeulen, L. C., Knol, M. J.
10.1101/2021.03.30.21253126 — Posted: 2021-04-06
Genomic epidemiology of SARS-CoV-2 in Russia reveals recurring cross-border transmission throughout 2020
Matsvay, A., Klink, G. V., Safina, K. R., Nabieva, E., Garushyants, S. K., Biba, D., Bazykin, G. A., Mikhaylov, I. M., Say, A. V., Zakamornaya, A. I., Khakhina, A. O., Lisitsa, T. S., Ayginin, A. A., Abramov, I. S., Bogdan, S. A., Kolbutova, K. B., Oleynikova, D. U., Avdeenko, T. F., Shipulin, G. A., Yudin, S. M., Skvortsova, V. I.
10.1101/2021.03.31.21254115 — Posted: 2021-04-06
Timing is everything: the relationship between COVID outcomes and the date at which mask mandates are relaxed
Shoukat, A., Galvani, A. P., Fitzpatrick, M. C.
10.1101/2021.03.31.21254646 — Posted: 2021-04-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).